US › Healthcare

Biotricity Inc (BTCY)

US · Healthcare · Medical Devices

$0.11+13.68%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$4.3M

Revenue YoY

+10.4%

Net profit

$-959,468

EPS

$-0.04

EPS estimate

$-0.11

Net margin

-22.4%

EPS came in at -0.04 against a street estimate of -0.11 — a beat of 63.6%.

Key statistics

Market cap

$2.2M

Forward P/E

0.0

P/B

29.92

Book value

$-1.87

EPS (TTM)

$-0.13

52-week high

$0.75

52-week low

$0.09

50-day MA

$0.11

200-day MA

$0.21

Beta

1.17

Analyst view

Analysts rate Biotricity Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $4.00.

Shareholding

Insiders

1.18%

Institutions

1.22%

Largest institutional holders

Fund	Stake
Strengthening Families & Communities, LLC	0.24%
Sfam, LLC	0.09%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biotricity Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.